Assessment of healthcare resource utilization and direct medical cost in relation to treatment length of oral corticosteroids in biologic initiated patients with ulcerative colitis: a Japanese claims database study
Analysis reveals differences in healthcare resource utilization and costs after biologic initiation in ulcerative colitis patients, highlighting treatment duration effects.
Key Points
Biologic initiation significantly reduced healthcare resource utilization and inpatient costs for ulcerative colitis patients.
Patients using oral corticosteroids for less than 180 days had shorter median time to discontinuation compared to those using it longer.
Inpatient medical costs decreased, while outpatient costs increased post-index, illustrating diverse financial impacts.
Overall healthcare resource utilization dynamics were consistent between patients with short and long durations of corticosteroid use.